Global Drug Toxicity Trends

A study of adverse drug effects during myeloma treatment

A study conducted by Shahzad Raza, Majid Jaberi-Douraki, and colleagues analyzed the adverse effects of drugs used in the treatment of multiple myeloma, a type of cancer. The study examined data from the FDA Adverse Event Reporting System (FAERS) from 2003 to 2022, categorizing patients based on age, sex, and geographical location. The findings showed variations in specific adverse effects across different regions, such as heart and blood vessel issues being more common in North America and Europe, kidney problems more prevalent in Africa, and nerve problems more frequent in Europe and among females. The study also revealed a higher likelihood of mortality resulting from these issues in Asia and Europe compared to North America. Additionally, the researchers observed that certain cancers, including skin cancer and breast cancer, were more prevalent in specific regions. The differences in adverse effects may be influenced by factors such as genetics, drug usage practices, coexisting health conditions, age, and sex. The study authors suggested further research to improve patient care, reduce complications, lower mortality rates, and optimize healthcare resource utilization.

• Heart and blood vessel issues were more common in North America and Europe compared to other regions.
• Kidney problems were more prevalent in Africa.
• Nerve problems were more frequent in Europe and among females.
• The chances of dying from drug-related problems were higher in Asia and Europe compared to North America.
• Certain cancers, like skin cancer and breast cancer, were more common in specific regions.
• Differences in adverse effects may be influenced by genetics, drug usage practices, coexisting health conditions, age, and sex.
• Further research is recommended to improve patient care, reduce complications, lower mortality rates, and optimize healthcare resource utilization.